Safety profile of nivolumab (NIVO) and ipilimumab (IPI) combination therapy in patients with advanced melanoma (MEL) Meeting Abstract


Authors: Sznol, M.; Ferrucci, P.; Hogg, D.; Atkins, M.; Wolter, P.; Guidoboni, M.; Lebbe, C.; Kirkwood, J.; Schachter, J.; Daniels, G.; Hassel, J.; Cebon, J.; Gerritsen, W.; Atkinson, V.; Thomas, L.; McCaffrey, J.; Power, D.; Jiang, J.; Hodi, S.; Wolchok, J.
Abstract Title: Safety profile of nivolumab (NIVO) and ipilimumab (IPI) combination therapy in patients with advanced melanoma (MEL)
Meeting Title: COSA's 43rd Annual Scientific Meeting
Journal Title: Asia-Pacific Journal of Clinical Oncology
Volume: 12
Issue: Suppl. 5
Meeting Dates: 2016 Nov 15-17
Meeting Location: Queensland, Australia
ISSN: 1743-7555
Publisher: Wiley Blackwell  
Date Published: 2016-11-01
Start Page: 118
Language: English
ACCESSION: WOS:000387769900166
PROVIDER: wos
DOI: 10.1111/ajco.12646
Notes: Meeting Abstract: 216 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok